Editorials

Optimising the investigation of meningococcal disease

BMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7111.757 (Published 27 September 1997) Cite this as: BMJ 1997;315:757

Early treatment with benzylpenicillin is important and doesn't jeopardise diagnosis

  1. Keith Cartwright, Secretary PHLS meningococcus working groupa,
  2. Simon Kroll, Professor of paediatrics and molecular infectious diseasesb
  1. a PHLS South West Directorate Office, Gloucestershire Royal Hospital, Gloucester GL1 3NN,
  2. b Imperial College School of Medicine, St Mary's Hospital, London W2 1PG

    The incidence of meningococcal disease in England and Wales has remained at high levels over the past two winters, as has the proportion of cases caused by strains of serogroup C (M Ramsay, E Kaczmarski, personal communications). Clusters, also caused mainly by serogroup C strains, have increased considerably, particularly among students at schools and universities (A Rushdy, J Stuart, personal communications). While effective vaccines are awaited, current priorities are to optimise recognition, diagnosis, and management.

    Administration of benzylpenicillin to suspected cases before admission to hospital reduces mortality1 and is advocated by the United Kingdom's chief medical officers. Though now used more widely, continuing failure to implement this simple measure2 may be due to a misplaced fear of obscuring the diagnosis and thereby jeopardising management.

    After an injection of benzylpenicillin blood culture is rarely positive and, though cerebrospinal fluid may still yield meningococci,3 lumbar puncture is an increasingly controversial investigation in suspected meningococcal disease. …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe